Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Coltro G, Lasho TL, Finke CM, Gangat N, Pardanani A, Tefferi A, Jevremovic D, Altman JK, Patnaik MM.

Am J Hematol. 2019 Jun 7. doi: 10.1002/ajh.25552. [Epub ahead of print] No abstract available.

PMID:
31173385
2.

Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.

Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P.

Cytometry B Clin Cytom. 2019 Apr 11. doi: 10.1002/cyto.b.21782. [Epub ahead of print]

PMID:
30972977
3.

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.

Tschautscher MA, Jevremovic D, Rajkumar V, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Dingli D, Hwa YL, Fonder AL, Hobbs MA, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Lin Y, Gonsalves WI, Kourelis T, Warsame R, Kyle RA, Kumar SK.

Am J Hematol. 2019 Jul;94(7):751-756. doi: 10.1002/ajh.25481. Epub 2019 Apr 30.

PMID:
30945330
4.

Flow Cytometry Applications in the Diagnosis of T/NK-Cell Lymphoproliferative Disorders.

Jevremovic D, Olteanu H.

Cytometry B Clin Cytom. 2019 Mar;96(2):99-115. doi: 10.1002/cyto.b.21768. Epub 2019 Feb 6. Review.

PMID:
30729667
5.

Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma.

Sidana S, Jevremovic D, Ketterling RP, Tandon N, Greipp PT, Baughn LB, Dispenzieri A, Gertz MA, Rajkumar SV, Kumar SK.

Am J Hematol. 2019 May;94(5):E117-E120. doi: 10.1002/ajh.25420. Epub 2019 Feb 6. No abstract available.

PMID:
30680770
6.

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.

Sidana S, Jevremovic D, Ketterling RP, Tandon N, Dispenzieri A, Gertz MA, Greipp PT, Baughn LB, Buadi FK, Lacy MQ, Morice W, Hanson C, Timm M, Dingli D, Hayman SR, Gonsalves WI, Kapoor P, Kyle RA, Leung N, Go RS, Lust JA, Rajkumar SV, Kumar SK.

Am J Hematol. 2019 Apr;94(4):424-430. doi: 10.1002/ajh.25391. Epub 2019 Jan 8.

PMID:
30592078
7.

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0102-7.

PMID:
30568288
8.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30510265
9.

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma.

Aljama MA, Sidiqi MH, Lakshman A, Dispenzieri A, Jevremovic D, Gertz MA, Lacy MQ, Buadi FK, Dingli D, Muchtar E, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Warsame R, Kourelis TV, Hwa YL, Kapoor P, Leung N, Go RS, Kyle RA, Rajkumar SV, Kumar SK.

Blood Adv. 2018 Nov 27;2(22):3149-3154. doi: 10.1182/bloodadvances.2018024794.

10.

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response.

Sidiqi MH, Aljama MA, Jevremovic D, Morice WG, Timm M, Buadi FK, Warsame R, Lacy MQ, Dispenzieri A, Dingli D, Gonsalves WI, Kumar S, Kapoor P, Kourelis T, Leung N, Hogan WJ, Muchtar E, Lust JA, Rajkumar VS, Gertz MA.

Bone Marrow Transplant. 2019 Mar;54(3):442-447. doi: 10.1038/s41409-018-0280-8. Epub 2018 Aug 7.

PMID:
30087461
11.

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis.

Sidiqi MH, Aljama MA, Jevremovic D, Muchtar E, Buadi FK, Warsame R, Lacy MQ, Dispenzieri A, Dingli D, Gonsalves WI, Kumar S, Kapoor P, Kourelis T, Leung N, Hogan WJ, Gertz MA.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2360-2364. doi: 10.1016/j.bbmt.2018.06.027. Epub 2018 Jun 30.

PMID:
29964192
12.

Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.

Neff JL, Rangan A, Jevremovic D, Nguyen PL, Chiu A, Go RS, Chen D, Morice WG, Shi M.

Hum Pathol. 2018 Nov;81:96-104. doi: 10.1016/j.humpath.2018.06.023. Epub 2018 Jun 24.

PMID:
29949739
13.

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1037-1046. doi: 10.2215/CJN.13041117. Epub 2018 May 30.

PMID:
29848505
14.

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.

Sidiqi MH, Aljama MA, Jevremovic D, Morice WG, Timm M, Buadi FK, Warsame R, Lacy MQ, Dispenzieri A, Dingli D, Gonsalves WI, Kumar S, Kapoor P, Kourelis T, Leung N, Hogan WJ, Gertz M.

Haematologica. 2018 Jul;103(7):1229-1234. doi: 10.3324/haematol.2018.189985. Epub 2018 Apr 19.

15.

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.

Sidana S, Tandon N, Dispenzieri A, Gertz MA, Dingli D, Jevremovic D, Morice WG, Kapoor P, Kourelis TV, Lacy MQ, Hayman SR, Buadi FK, Leung N, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust SR, Warsame R, Hwa YL, Hobbs M, Fonder A, Kyle RA, Rajkumar SV, Kumar SK, Gonsalves WI.

Leukemia. 2018 Jun;32(6):1421-1426. doi: 10.1038/s41375-018-0063-7. Epub 2018 Feb 21.

16.

T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group.

Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED.

Am J Clin Pathol. 2018 Jan 29;149(2):164-171. doi: 10.1093/ajcp/aqx146.

PMID:
29365010
17.

Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.

Gonsalves WI, Ramakrishnan V, Hitosugi T, Ghosh T, Jevremovic D, Dutta T, Sakrikar D, Petterson XM, Wellik L, Kumar SK, Nair KS.

JCI Insight. 2018 Jan 11;3(1). pii: 94543. doi: 10.1172/jci.insight.94543. eCollection 2018 Jan 11.

18.

STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.

Shi M, He R, Feldman AL, Viswanatha DS, Jevremovic D, Chen D, Morice WG.

Hum Pathol. 2018 Mar;73:74-81. doi: 10.1016/j.humpath.2017.12.014. Epub 2017 Dec 27.

PMID:
29288042
19.

Immunophenotypic and laboratory features of t(11;14)(q13;q32)-positive plasma cell neoplasms.

Shi M, Ternus JA, Ketterling RP, Jevremovic D, McPhail ED.

Leuk Lymphoma. 2018 Aug;59(8):1913-1919. doi: 10.1080/10428194.2017.1410885. Epub 2017 Dec 7.

PMID:
29214874
20.

Flow Cytometric Assessment of Chronic Myeloid Neoplasms.

Shi M, Nguyen P, Jevremovic D.

Clin Lab Med. 2017 Dec;37(4):803-819. doi: 10.1016/j.cll.2017.07.006. Epub 2017 Sep 20. Review.

PMID:
29128070
21.

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis.

Patnaik MM, Timm MM, Vallapureddy R, Lasho TL, Ketterling RP, Gangat N, Shi M, Tefferi A, Solary E, Reichard KK, Jevremovic D.

Blood Cancer J. 2017 Jul 21;7(7):e584. doi: 10.1038/bcj.2017.66. No abstract available.

22.

TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL.

Kremer KN, Dinkel BA, Sterner RM, Osborne DG, Jevremovic D, Hedin KE.

Blood. 2017 Aug 24;130(8):982-994. doi: 10.1182/blood-2017-03-770982. Epub 2017 Jul 10.

23.

A rash with a heavy heart.

Barros-Gomes S, Naksuk N, Jevremovic D, Villarraga HR.

Echo Res Pract. 2017 Jul 7. pii: ERP-17-0021. doi: 10.1530/ERP-17-0021. [Epub ahead of print]

24.

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.

Ghosh T, Gonsalves WI, Jevremovic D, Dispenzieri A, Dingli D, Timm MM, Morice WG, Kapoor P, Kourelis TV, Lacy MQ, Hayman SR, Buadi FK, Leung N, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust SR, Warsame R, Hwa YL, Kyle RA, Gertz MA, Vincent Rajkumar S, Kumar SK.

Am J Hematol. 2017 Sep;92(9):E507-E512. doi: 10.1002/ajh.24807. Epub 2017 Jul 19.

25.

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.

Chakraborty R, Muchtar E, Kumar SK, Jevremovic D, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA.

Haematologica. 2017 Aug;102(8):1439-1445. doi: 10.3324/haematol.2017.166629. Epub 2017 May 4.

26.

Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue.

Pham AQ, Broski SM, Habermann TM, Jevremovic D, Wiseman GA, Feldman AL, Maurer MJ, Ristow KM, Witzig TE.

Leuk Lymphoma. 2017 Oct;58(10):2342-2348. doi: 10.1080/10428194.2017.1300891. Epub 2017 Mar 14.

PMID:
28290723
27.

Plasmacytoma of the Temporal Bone, a Great Imitator: Report of Seven Cases and Comprehensive Review of the Literature.

Sweeney AD, Hunter JB, Rajkumar SV, Lane JI, Jevremovic D, Carlson ML.

Otol Neurotol. 2017 Mar;38(3):400-407. doi: 10.1097/MAO.0000000000001317. Review.

PMID:
28192381
28.

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

Chakraborty R, Muchtar E, Kumar SK, Jevremovic D, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA.

Biol Blood Marrow Transplant. 2017 Apr;23(4):598-605. doi: 10.1016/j.bbmt.2017.01.076. Epub 2017 Jan 20.

29.

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB.

JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. Review.

30.

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.

Chakraborty R, Muchtar E, Kumar SK, Jevremovic D, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA.

Blood Cancer J. 2016 Dec 16;6(12):e512. doi: 10.1038/bcj.2016.117.

31.

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment.

Muchtar E, Jevremovic D, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Gonsalves W, Hayman SR, Kapoor P, Leung N, Russell S, Lust JA, Lin Y, Go RS, Chakraborty R, Zeldenrust S, Kumar SK, Kyle RA, Rajkumar SV, Gertz MA.

Blood. 2017 Jan 5;129(1):82-87. doi: 10.1182/blood-2016-06-721878. Epub 2016 Oct 11.

32.

Disseminated Mycobacterium chimaera Infection After Cardiothoracic Surgery.

Tan N, Sampath R, Abu Saleh OM, Tweet MS, Jevremovic D, Alniemi S, Wengenack NL, Sampathkumar P, Badley AD.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw131. eCollection 2016 Sep.

33.

LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.

Jevremovic D, Roden AC, Ketterling RP, Kurtin PJ, McPhail ED.

Am J Clin Pathol. 2016 Feb;145(2):180-90. doi: 10.1093/ajcp/aqv024. Epub 2016 Jan 21.

PMID:
26796495
34.

Decreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia.

Shi M, Neff JL, Jevremovic D, Morice WG.

Leuk Lymphoma. 2016 May;57(5):1230-3. doi: 10.3109/10428194.2015.1081191. Epub 2015 Dec 21. No abstract available.

PMID:
26689813
35.

Addition of a Fluoride-containing Radiopacifier Improves Micromechanical and Biological Characteristics of Modified Calcium Silicate Cements.

Antonijevic D, Jeschke A, Colovic B, Milovanovic P, Jevremovic D, Kisic D, vom Scheidt A, Hahn M, Amling M, Jokanovic V, Busse B, Djuric M.

J Endod. 2015 Dec;41(12):2050-7. doi: 10.1016/j.joen.2015.09.008. Epub 2015 Oct 28.

PMID:
26518217
36.

Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.

Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D, Isenovic ER.

Crit Rev Clin Lab Sci. 2015;52(2):70-85. doi: 10.3109/10408363.2014.992063. Epub 2014 Dec 24. Review.

PMID:
25537066
37.

A Comparative Analysis of the Corrosive Effect of Artificial Saliva of Variable pH on DMLS and Cast Co-Cr-Mo Dental Alloy.

Puskar T, Jevremovic D, Williams RJ, Eggbeer D, Vukelic D, Budak I.

Materials (Basel). 2014 Sep 11;7(9):6486-6501. doi: 10.3390/ma7096486.

38.

First Report of Anthracnose on Alfalfa Caused by Colletotrichum linicola in Serbia.

Vasić T, Bulajić A, Krnjaja V, Jevremović D, Živković S, Andjelković B.

Plant Dis. 2014 Sep;98(9):1276. doi: 10.1094/PDIS-03-14-0258-PDN.

PMID:
30699627
39.

Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms.

Jevremovic D, Timm MM, Reichard KK, Morice WG, Hanson CA, Viswanatha DS, Howard MT, Nguyen PL.

Am J Clin Pathol. 2014 Sep;142(3):292-8. doi: 10.1309/AJCP73QSLLYDEGXK.

PMID:
25125617
40.

High-Sensitivity C-Reactive Protein and Statin Initiation.

Trpkovic A, Stanimirovic J, Rizzo M, Resanovic I, Soskic S, Jevremovic D, Isenovic ER.

Angiology. 2015 Jul;66(6):503-7. doi: 10.1177/0003319714543000. Epub 2014 Jul 22. Review.

PMID:
25053677
41.

Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2.

Smiljanic K, Obradovic M, Jovanovic A, Djordjevic J, Dobutovic B, Jevremovic D, Marche P, Isenovic ER.

Mol Cell Biochem. 2014 Nov;396(1-2):147-60. doi: 10.1007/s11010-014-2151-y. Epub 2014 Jul 22.

PMID:
25047892
42.

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteria.

Wood B, Jevremovic D, Béné MC, Yan M, Jacobs P, Litwin V; ICSH/ICCS Working Group.

Cytometry B Clin Cytom. 2013 Sep-Oct;84(5):315-23. doi: 10.1002/cyto.b.21108. Review.

43.

Morphological and biomechanical features of the temporomandibular joint disc: an overview of recent findings.

Stanković S, Vlajković S, Bošković M, Radenković G, Antić V, Jevremović D.

Arch Oral Biol. 2013 Oct;58(10):1475-82. doi: 10.1016/j.archoralbio.2013.06.014. Epub 2013 Jul 18. Review.

PMID:
23871384
44.

Finding minimal generating set for metabolic network with reversible pathways.

Jevremović D, Boley D.

Biosystems. 2013 Apr;112(1):31-6. doi: 10.1016/j.biosystems.2013.02.003. Epub 2013 Mar 6.

PMID:
23474418
45.

Identification and Characterization of Eutypa lata on Grapevine in Serbia.

Živkoviċ S, Vasiċ T, Anđelković S, Jevremoviċ D, Trkulja V.

Plant Dis. 2012 Jun;96(6):913. doi: 10.1094/PDIS-11-11-0990-PDN.

PMID:
30727396
46.

An in vitro radiographic analysis of the density of dental luting cements as measured by CCD-based digital radiography.

Antonijevic D, Jevremovic D, Jovanovic S, Obradovic-Djuricic K.

Quintessence Int. 2012 May;43(5):421-8.

PMID:
22536594
47.

Parallelization of Nullspace Algorithm for the computation of metabolic pathways.

Jevremović D, Trinh CT, Srienc F, Sosa CP, Boley D.

Parallel Comput. 2011 Jun;37(6-7):261-278.

48.

Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.

Kovtun IV, Harris KJ, Jatoi A, Jevremovic D.

Carcinogenesis. 2011 Jul;32(7):1085-92. doi: 10.1093/carcin/bgr080. Epub 2011 May 5.

49.

Mediterranean and central-eastern European countries host viruses of two different clades of plum pox virus strain M.

Dallot S, Glasa M, Jevremovic D, Kamenova I, Paunovic S, Labonne G.

Arch Virol. 2011 Mar;156(3):539-42. doi: 10.1007/s00705-011-0918-y. Epub 2011 Feb 4.

PMID:
21293968
50.

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.

Dronca RS, Jevremovic D, Hanson CA, Rabe KG, Shanafelt TD, Morice WG, Call TG, Kay NE, Collins CS, Schwager SM, Slager SL, Zent CS.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S35-41. doi: 10.1002/cyto.b.20546.

Supplemental Content

Loading ...
Support Center